Evaluation of the anti-CCR4 monoclonal antibody Mogamulizumab in advanced cutaneous T-cell lymphomas and with large cell transformation.

IF 11 1区医学 Q1 DERMATOLOGY

British Journal of Dermatology Pub Date : 2025-04-07 DOI:10.1093/bjd/ljaf125

Lou Faltot, Marie Donzel, Georgio Chidiac, Brigitte Balme, Nicolas Romain-Scelle, Marie Perier-Muzet, Stéphane Dalle

引用次数: 0

查看原文本刊更多论文

抗ccr4单克隆抗体Mogamulizumab在晚期皮肤t细胞淋巴瘤和大细胞转化中的评价

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Dermatology 医学-皮肤病学

CiteScore

16.30

自引率

3.90%

发文量

1062

审稿时长

2-4 weeks

期刊介绍： The British Journal of Dermatology (BJD) is committed to publishing the highest quality dermatological research. Through its publications, the journal seeks to advance the understanding, management, and treatment of skin diseases, ultimately aiming to improve patient outcomes.